Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics.
暂无分享,去创建一个
[1] Sunitha Nagrath,et al. Microfluidics and cancer: are we there yet? , 2013, Biomedical microdevices.
[2] David A. Cheresh,et al. Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.
[3] J. Nör,et al. The Perivascular Niche and Self-Renewal of Stem Cells , 2015, Front. Physiol..
[4] Z. Werb,et al. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? , 2015, Cell stem cell.
[5] S. Pun,et al. 3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers. , 2008, Bioconjugate chemistry.
[6] Linheng Li,et al. Normal stem cells and cancer stem cells: the niche matters. , 2006, Cancer research.
[7] A. Pietras. Cancer stem cells in tumor heterogeneity. , 2011, Advances in cancer research.
[8] Jan Paul Medema,et al. Intra-tumor heterogeneity from a cancer stem cell perspective , 2017, Molecular Cancer.
[9] M. Mason,et al. Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts , 2014, Oncotarget.
[10] Jong-Wan Park,et al. Oxygen-dependent and -independent regulation of HIF-1alpha. , 2002, Journal of Korean medical science.
[11] O. Petersen,et al. Identification of EPSTI1, a novel gene induced by epithelial-stromal interaction in human breast cancer. , 2002, Genomics.
[12] Ossama Tawfik,et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt–β-catenin signaling , 2004, Nature Genetics.
[13] C. Heeschen,et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.
[14] Kenichi Funamoto,et al. A novel microfluidic platform for high-resolution imaging of a three-dimensional cell culture under a controlled hypoxic environment. , 2012, Lab on a chip.
[15] O. Yesil‐Celiktas,et al. Diffusion phenomena of cells and biomolecules in microfluidic devices. , 2015, Biomicrofluidics.
[16] Qi Wang,et al. Functional Investigation of NCI-H460-Inducible Myofibroblasts on the Chemoresistance to VP-16 with a Microfluidic 3D Co-Culture Device , 2013, PloS one.
[17] Q. Sang,et al. The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis. , 2004, Experimental cell research.
[18] Sally Temple,et al. Endothelial Cells Stimulate Self-Renewal and Expand Neurogenesis of Neural Stem Cells , 2004, Science.
[19] L. D. Pillis,et al. A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth , 2005 .
[20] Ash A. Alizadeh,et al. Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 , 2010, Science Translational Medicine.
[21] Benjamin J. Raphael,et al. Advances for studying clonal evolution in cancer. , 2013, Cancer letters.
[22] S. Terry,et al. Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia. , 2015, American journal of physiology. Cell physiology.
[23] F. Pampaloni,et al. The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.
[24] D. Pappas,et al. Observation of reversible, rapid changes in drug susceptibility of hypoxic tumor cells in a microfluidic device. , 2016, Analytica chimica acta.
[25] Chu Zhang,et al. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. , 2009, Biomaterials.
[26] L. Carrascosa,et al. Real time and label free profiling of clinically relevant exosomes , 2016, Scientific Reports.
[27] E. Cukierman,et al. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells , 2011, BMC Cancer.
[28] R. L. Baldwin,et al. A human ovarian carcinoma murine xenograft model useful for preclinical trials. , 2002, Gynecologic oncology.
[29] E. Yeh,et al. Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy , 2016, npj Breast Cancer.
[30] R. Garofalo,et al. Oxygen-Independent Stabilization of Hypoxia Inducible Factor (HIF)-1 during RSV Infection , 2008, PloS one.
[31] N. Forbes,et al. Microfluidic device for recreating a tumor microenvironment in vitro. , 2011, Journal of visualized experiments : JoVE.
[32] Haitao Niu,et al. Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device , 2015, Cell cycle.
[33] G. Vunjak‐Novakovic,et al. Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model , 2016, Theranostics.
[34] Fei Xing,et al. Cancer associated fibroblasts (CAFs) in tumor microenvironment. , 2010, Frontiers in bioscience.
[35] John S. Condeelis,et al. Chemotaxis in cancer , 2011, Nature Reviews Cancer.
[36] M. Maharbiz,et al. Micrometer‐scale oxygen delivery rearranges cells and prevents necrosis in tumor tissue in vitro , 2012, Biotechnology progress.
[37] A. Sood,et al. Monocyte subpopulations in angiogenesis. , 2014, Cancer research.
[38] F. Wang,et al. Glucose-regulated protein 78 and heparanase expression in oral squamous cell carcinoma: correlations and prognostic significance , 2014, World Journal of Surgical Oncology.
[39] Kenneth M. Yamada,et al. Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.
[40] A. Puisieux,et al. Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.
[41] Louis Vermeulen,et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.
[42] J. Minna,et al. Stromal and Epithelial Expression of Tumor Markers Hyaluronic Acid and HYAL1 Hyaluronidase in Prostate Cancer* , 2001, The Journal of Biological Chemistry.
[43] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[44] M. Noble,et al. Cancer stem cells. , 2006, The New England journal of medicine.
[45] E. Holland,et al. Genetically engineered models have advantages over xenografts for preclinical studies. , 2006, Cancer research.
[46] E. Butcher,et al. T cell chemotaxis in a simple microfluidic device. , 2006, Lab on a chip.
[47] Shuichi Takayama,et al. Quantitative measurement and control of oxygen levels in microfluidic poly(dimethylsiloxane) bioreactors during cell culture , 2007, Biomedical microdevices.
[48] Till Acker,et al. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function , 2000, Oncogene.
[49] J. Thiery,et al. Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer , 2007, Clinical & Experimental Metastasis.
[50] P. Kim,et al. Droplet-based microtumor model to assess cell-ECM interactions and drug resistance of gastric cancer cells , 2017, Scientific Reports.
[51] David J. Beebe,et al. Understanding the Impact of 2D and 3D Fibroblast Cultures on In Vitro Breast Cancer Models , 2013, PloS one.
[52] A. Uccelli,et al. Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.
[53] Sara Rockwell,et al. Hypoxia and radiation therapy: past history, ongoing research, and future promise. , 2009, Current molecular medicine.
[54] Andrew J. Ewald,et al. Three-dimensional organotypic culture: experimental models of mammalian biology and disease , 2014, Nature Reviews Molecular Cell Biology.
[55] A. Harris,et al. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .
[56] S. Lim,et al. Understanding the Roles of FAK in Cancer , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[57] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[58] I. Bayazitov,et al. A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.
[59] C. Fimognari,et al. Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment , 2016, Oncotarget.
[60] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[61] F. Lin,et al. Neutrophil migration under spatially-varying chemoattractant gradient profiles , 2015, Biomedical Microdevices.
[62] L. Prantl,et al. Limitation of in vivo models investigating angiogenesis in breast cancer. , 2011, Clinical hemorheology and microcirculation.
[63] C. Michiels,et al. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. , 2008, Anti-cancer agents in medicinal chemistry.
[64] Paolo A Netti,et al. An Engineered Breast Cancer Model on a Chip to Replicate ECM‐Activation In Vitro during Tumor Progression , 2016, Advanced healthcare materials.
[65] Katsuo Kurabayashi,et al. Emerging Microfluidic Tools for Functional Cellular Immunophenotyping: A New Potential Paradigm for Immune Status Characterization , 2013, Front. Oncol..
[66] S. Gerecht,et al. Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships. , 2015, Free radical biology & medicine.
[67] R. Kramer,et al. Invasion of reconstituted basement membrane matrix by metastatic human tumor cells. , 1986, Cancer research.
[68] Hui Wang,et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.
[69] V. Golubovskaya,et al. Focal adhesion kinase and cancer. , 2009, Histology and histopathology.
[70] Bingcheng Lin,et al. Carcinoma-associated fibroblasts promoted tumor spheroid invasion on a microfluidic 3D co-culture device. , 2010, Lab on a chip.
[71] Irving L Weissman,et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.
[72] Jianru Xiao,et al. Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma , 2017, Scientific Reports.
[73] J. Massagué,et al. Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.
[74] Byungwook Ahn,et al. Endothelialized microfluidics for studying microvascular interactions in hematologic diseases. , 2012, Journal of visualized experiments : JoVE.
[75] Wenming Liu,et al. Construction of oxygen and chemical concentration gradients in a single microfluidic device for studying tumor cell-drug interactions in a dynamic hypoxia microenvironment. , 2013, Lab on a chip.
[76] Russell Hughes,et al. Tumor-associated macrophages: effectors of angiogenesis and tumor progression. , 2009, Biochimica et biophysica acta.
[77] H. Iishi,et al. Retaining cell–cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer , 2011, Proceedings of the National Academy of Sciences.
[78] Irving L. Weissman,et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.
[79] Justin C. Williams,et al. Microfluidics-based devices: New tools for studying cancer and cancer stem cell migration. , 2011, Biomicrofluidics.
[80] I. Tannock,et al. Drug penetration in solid tumours , 2006, Nature Reviews Cancer.
[81] Liliana Attisano,et al. Synergistic Cooperation between Hypoxia and Transforming Growth Factor-β Pathways on Human Vascular Endothelial Growth Factor Gene Expression* , 2001, The Journal of Biological Chemistry.
[82] F. Agani,et al. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. , 2013, Current cancer drug targets.
[83] Sarah E Seton-Rogers. Metastasis: Multitasking hyaluronic acid , 2012, Nature Reviews Cancer.
[84] Chien-Chung Peng,et al. Generation of oxygen gradients in microfluidic devices for cell culture using spatially confined chemical reactions. , 2011, Lab on a chip.
[85] M. Clarke,et al. Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy , 2008, PloS one.
[86] M. Karin,et al. Tumor promotion via injury- and death-induced inflammation. , 2011, Immunity.
[87] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[88] J. Rich. Cancer stem cells: understanding tumor hierarchy and heterogeneity , 2016, Medicine.
[89] F. Sotgia,et al. Cancer stem cell metabolism , 2016, Breast Cancer Research.
[90] David A. Cheresh,et al. Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.
[91] G. C. Chan,et al. Microencapsulation of Neuroblastoma Cells and Mesenchymal Stromal Cells in Collagen Microspheres: A 3D Model for Cancer Cell Niche Study , 2015, PloS one.
[92] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[93] Miguel A. Acosta,et al. A microfluidic device to study cancer metastasis under chronic and intermittent hypoxia. , 2014, Biomicrofluidics.
[94] Dietmar W Hutmacher,et al. Biomaterials offer cancer research the third dimension. , 2010, Nature materials.
[95] C. Brennan,et al. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. , 2010, Cell stem cell.
[96] Claudia Hoffmann,et al. Integrating Macrophages into Organotypic Co-Cultures: A 3D In Vitro Model to Study Tumor-Associated Macrophages , 2012, PloS one.
[97] C. Michiels,et al. Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours , 2008, The FEBS journal.
[98] S. Glynn,et al. Mesenchymal stem cells: key players in cancer progression , 2017, Molecular Cancer.
[99] C. Haslinger,et al. Modeling colon adenocarcinomas in vitro a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction. , 2011, The American journal of pathology.
[100] M. Simpson,et al. Emerging roles for hyaluronidase in cancer metastasis and therapy. , 2014, Advances in cancer research.
[101] Young Seok Kim,et al. Low production of reactive oxygen species and high DNA repair: mechanism of radioresistance of prostate cancer stem cells. , 2013, Anticancer research.
[102] Mina J. Bissell,et al. The perivascular niche regulates breast tumor dormancy , 2013, Nature Cell Biology.
[103] H. Earp,et al. Targeting the TAM Receptors in Leukemia , 2016, Cancers.
[104] A. Phillips,et al. Hyaluronan Facilitates Transforming Growth Factor-β1-dependent Proliferation via CD44 and Epidermal Growth Factor Receptor Interaction , 2011, The Journal of Biological Chemistry.
[105] Jianguo Zhang,et al. high expression of glucose-regulated protein 78 ( grP 78 ) is associated with metastasis and poor prognosis in patients with esophageal squamous cell carcinoma , 2017 .
[106] A. Harris,et al. Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability. , 2010, Cancer research.
[107] L. Qin,et al. Utilizing a high-throughput microfluidic platform to study hypoxia-driven mesenchymal-mode cell migration. , 2015, Integrative biology : quantitative biosciences from nano to macro.
[108] F. Su,et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.
[109] P. Hoff,et al. Unraveling the role of hypoxia-inducible factor (HIF)-1α and HIF-2α in the adaption process of human microvascular endothelial cells (HMEC-1) to hypoxia: Redundant HIF-dependent regulation of macrophage migration inhibitory factor. , 2018, Microvascular research.
[110] R. Gillies,et al. Intermittent Hypoxia Selects for Genotypes and Phenotypes That Increase Survival, Invasion, and Therapy Resistance , 2015, PloS one.
[111] Raphael Kopan,et al. The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.
[112] J. Huse,et al. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. , 2014, Cell stem cell.
[113] F. Braet,et al. Planar microfluidic chamber for generation of stable and steep chemoattractant gradients. , 2008, Biophysical journal.
[114] Kevin J. Harrington,et al. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence , 2015, Nature Reviews Cancer.
[115] Elena Agliari,et al. Cancer-driven dynamics of immune cells in a microfluidic environment , 2014, Scientific Reports.
[116] Jos Jonkers,et al. Genetically engineered mouse models in oncology research and cancer medicine , 2016, EMBO molecular medicine.
[117] Peter Kuhn,et al. A rare-cell detector for cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[118] David J Mooney,et al. Can tissue engineering concepts advance tumor biology research? , 2010, Trends in biotechnology.
[119] A. Przylipiak,et al. Protective influence of hyaluronic acid on focal adhesion kinase activity in human skin fibroblasts exposed to ethanol , 2017, Drug design, development and therapy.
[120] R. M. Sharrard,et al. Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures , 2001, British Journal of Cancer.
[121] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[122] Justin C. Williams,et al. Evaluation of Cancer Stem Cell Migration Using Compartmentalizing Microfluidic Devices and Live Cell Imaging , 2011, Journal of visualized experiments : JoVE.
[123] M. Cristofanilli,et al. Cancer stem cells: implications for cancer therapy. , 2014, Oncology.
[124] T. Wurdinger,et al. Microfluidic isolation and transcriptome analysis of serum microvesicles. , 2010, Lab on a chip.
[125] A. Khademhosseini,et al. BIOMIMETIC GRADIENT HYDROGELS FOR TISSUE ENGINEERING. , 2010, The Canadian journal of chemical engineering.
[126] W. Lam,et al. 3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitro. , 2017, Lab on a chip.
[127] David T Eddington,et al. Precise control over the oxygen conditions within the Boyden chamber using a microfabricated insert. , 2010, Lab on a chip.
[128] R. Clarkson,et al. The Complex Nature of Breast Cancer Stem-Like Cells: Heterogeneity and Plasticity , 2013 .
[129] Z. Trajanoski,et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. , 2013, Immunity.
[130] David T Eddington,et al. Oxygen gradients for open well cellular cultures via microfluidic substrates. , 2010, Lab on a chip.
[131] Brian Keith,et al. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.
[132] J Ratajczak,et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.
[133] A. Carnero,et al. The hypoxic microenvironment: A determinant of cancer stem cell evolution , 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.
[134] Wei Li,et al. HIF-1α pathway: role, regulation and intervention for cancer therapy , 2015, Acta pharmaceutica Sinica. B.
[135] Li Ying,et al. Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform , 2015, PloS one.
[136] Ji‐Hyun Lee,et al. Co-Culture of Tumor Spheroids and Fibroblasts in a Collagen Matrix-Incorporated Microfluidic Chip Mimics Reciprocal Activation in Solid Tumor Microenvironment , 2016, PloS one.
[137] S. Mohanam,et al. Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells , 2012, PloS one.
[138] S. Takayama,et al. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[139] Qi Wang,et al. Cancer-associated fibroblasts promote non-small cell lung cancer cell invasion by upregulation of glucose-regulated protein 78 (GRP78) expression in an integrated bionic microfluidic device , 2016, Oncotarget.
[140] Bingcheng Lin,et al. A microfluidic device for characterizing the invasion of cancer cells in 3‐D matrix , 2009, Electrophoresis.
[141] Robert A. Weinberg,et al. Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.
[142] E. Golemis,et al. Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. , 2008, Matrix biology : journal of the International Society for Matrix Biology.
[143] A. Halestrap. The monocarboxylate transporter family—Structure and functional characterization , 2012, IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology.
[144] P. Hersey,et al. Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells. , 2009, Carcinogenesis.
[145] Amy S. Lee,et al. Glucose regulated proteins in cancer progression, Drug resistance and immunotherapy , 2006, Cancer biology & therapy.
[146] S. Zhong,et al. Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs , 2014, PloS one.
[147] D. Tuveson,et al. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.
[148] He Zhu,et al. A microdevice for multiplexed detection of T-cell-secreted cytokines. , 2008, Lab on a chip.
[149] Vladimir P Torchilin,et al. Barriers to drug delivery in solid tumors , 2014, Tissue barriers.
[150] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[151] B. Rochat. Importance of influx and efflux systems and xenobiotic metabolizing enzymes in intratumoral disposition of anticancer agents. , 2009, Current cancer drug targets.
[152] N. Forbes,et al. Microfluidic technique to measure intratumoral transport and calculate drug efficacy shows that binding is essential for doxorubicin and release hampers Doxil. , 2013, Integrative biology : quantitative biosciences from nano to macro.
[153] M. Tsuboi,et al. Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts , 2016, Journal of Cancer Research and Clinical Oncology.
[154] K. Polyak,et al. Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.
[155] G. Whitesides,et al. Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device , 2002, Nature Biotechnology.
[156] E. Passegué,et al. Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils , 2015, Proceedings of the National Academy of Sciences.
[157] A. Orimo,et al. Carcinoma‐associated fibroblasts: Non‐neoplastic tumour‐promoting mesenchymal cells , 2013, Journal of cellular physiology.
[158] U. Lendahl,et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.
[159] P. Pandolfi,et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. , 2008, Genes & development.
[160] A. Karnoub,et al. Mesenchymal stem cells in tumor development , 2012, Cell adhesion & migration.
[161] Alberto Mantovani,et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.
[162] Annamaria Gerardino,et al. Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment. , 2013, Lab on a chip.
[163] D. Hollywood,et al. Hypoxia, notch signalling, and prostate cancer , 2013, Nature Reviews Urology.
[164] L. Vermeulen,et al. Cancer stem cell niche: the place to be. , 2011, Cancer research.
[165] Z. Werb,et al. Extracellular matrix degradation and remodeling in development and disease. , 2011, Cold Spring Harbor perspectives in biology.
[166] N. Altorki,et al. Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1 , 2015, Proceedings of the National Academy of Sciences.
[167] Jian-Long Xiao,et al. The migration speed of cancer cells influenced by macrophages and myofibroblasts co-cultured in a microfluidic chip. , 2012, Integrative biology : quantitative biosciences from nano to macro.
[168] C. Gialeli,et al. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.
[169] L. Xiao,et al. The cancer-associated fibroblasts and drug resistance. , 2015, European review for medical and pharmacological sciences.
[170] G. Dienel,et al. Lactate transport and transporters: General principles and functional roles in brain cells , 2005, Journal of neuroscience research.
[171] J. Griffin,et al. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion , 2009, British Journal of Cancer.
[172] Carlo C. Maley,et al. Clonal evolution in cancer , 2012, Nature.
[173] Brendon M. Baker,et al. Microfluidics embedded within extracellular matrix to define vascular architectures and pattern diffusive gradients. , 2013, Lab on a chip.
[174] Yong Wang,et al. Islet preconditioning via multimodal microfluidic modulation of intermittent hypoxia. , 2012, Analytical chemistry.
[175] D. Cheresh,et al. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. , 2015, Trends in cell biology.
[176] C. Blanpain,et al. Unravelling cancer stem cell potential , 2013, Nature Reviews Cancer.
[177] R. Germain,et al. T cell heterogeneity: firmly fixed, predominantly plastic or merely malleable? , 2008, Nature Immunology.
[178] James R Heath,et al. Nanotechnology and cancer. , 2008, Annual review of medicine.
[179] Sharon Gerecht,et al. Design and development of microbioreactors for long-term cell culture in controlled oxygen microenvironments , 2011, Biomedical Microdevices.
[180] L. weiswald,et al. Spherical Cancer Models in Tumor Biology1 , 2015, Neoplasia.
[181] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[182] Xin Lu,et al. Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis , 2010, Clinical Cancer Research.
[183] Rong Fan,et al. A Clinical Microchip for Evaluation of Single Immune Cells Reveals High Functional Heterogeneity in Phenotypically Similar T Cells Nih Public Access Author Manuscript Design Rationale and Detection Limit of the Scbc Online Methods Microchip Fabrication On-chip Secretion Profiling Supplementary Mater , 2022 .
[184] Karlyne M. Reilly,et al. Genetically engineered mouse models in cancer research. , 2010, Advances in cancer research.
[185] W. Farrar,et al. Radioresistance and Cancer Stem Cells: Survival of the Fittest , 2011 .
[186] Liju Yang,et al. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. , 2014, Assay and drug development technologies.
[187] D. Hong,et al. Exosome-mediated drug resistance in cancer: the near future is here , 2016, Therapeutic advances in medical oncology.
[188] Andreas Trumpp,et al. Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.
[189] P. Dutta,et al. Hypoxic behavior in cells under controlled microfluidic environment. , 2017, Biochimica et biophysica acta. General subjects.
[190] R. Weichselbaum,et al. Glioblastoma cells block radiation‐induced programmed cell death of endothelial cells , 2004, FEBS letters.
[191] Mark E. Polinkovsky,et al. Generation of oxygen gradients with arbitrary shapes in a microfluidic device. , 2010, Lab on a chip.
[192] Xian Xu,et al. Three-dimensional in vitro tumor models for cancer research and drug evaluation. , 2014, Biotechnology advances.
[193] R. Kamm,et al. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function , 2012, Proceedings of the National Academy of Sciences.
[194] Andrew J Ewald,et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium , 2012, Proceedings of the National Academy of Sciences.
[195] Aoife M Shannon,et al. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. , 2003, Cancer treatment reviews.
[196] M. Tzardi,et al. Cancer Microenvironment and Inflammation: Role of Hyaluronan , 2015, Front. Immunol..
[197] M. Bansal,et al. Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside of the crypt base stem cell niche , 2014, Nature Medicine.
[198] Donald W Kufe,et al. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[199] N. Itano,et al. Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment , 2014, Cancers.
[200] A. Krešo,et al. Evolution of the cancer stem cell model. , 2014, Cell stem cell.
[201] L. Bingle,et al. In vitro study of HIF‐1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI‐3K/Akt and MEK1/ERK pathways , 2005, The Journal of pathology.
[202] Ursula Pieper,et al. A role for matrix metalloproteinases in regulating mammary stem cell function via the Wnt signaling pathway. , 2013, Cell stem cell.
[203] Nikolay Bazhanov,et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties , 2010, Proceedings of the National Academy of Sciences.
[204] R. Sutherland. Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.